Search Login Register

Cytarabine (Cytosar-U) Summary

Description: A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)

Also Known As: Cytosar-U; Cytosine Arabinoside; Aracytidine; Aracytine; Cytarabine Hydrochloride Show All >>

Networked: 4912 relevant articles (664 outcomes, 866 trials/studies) for this Drug

Key Diseases for which Cytarabine is Relevant

  1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia) : 264 outcomes 291 studies in 1424 results
  2. Leukemia : 114 outcomes 179 studies in 1037 results
  3. Neoplasms (Cancer) : 47 outcomes 95 studies in 532 results
  4. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) : 42 outcomes 37 studies in 297 results
  5. Lymphoma (Lymphomas) : 32 outcomes 53 studies in 287 results
Show All >>

Drugs Related to Cytarabine

  1. Cytarabine (Cytosar-U)
  2. Daunorubicin (Cerubidine)
  3. Etoposide (VP 16)
  4. Mitoxantrone (Novantrone)
  5. Cyclophosphamide (Cytoxan)
  6. Vincristine (Oncovin)
  7. Doxorubicin (Adriamycin)
  8. Methotrexate (Mexate)
  9. fludarabine
  10. Idarubicin (4 Demethoxydaunorubicin)
Show All >>

Therapies Related to Cytarabine

  1. Drug Therapy (Chemotherapy)
  2. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  3. Remission Induction
  4. Combination Drug Therapy (Combination Chemotherapy)
  5. Stem Cell Transplantation
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.